ID   A1 [Human leukemia]
AC   CVCL_6G43
SY   A-1
DR   Wikidata; Q54606227
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1531243;
RX   PubMed=2595371;
CC   Doubling time: 48 hours (PubMed=1531243).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RA   Drexler H.G.;
RT   "The leukemia-lymphoma cell line factsbook.";
RL   (In) ISBN 9780122219702; pp.1-733; Academic Press; London (2001).
//
RX   PubMed=1531243;
RA   Kamel-Reid S., Dick J.E., Greaves A., Murdoch B., Doedens M.,
RA   Grunberger T., Thorner P.S., Freedman M.H., Phillips R.A., Letarte M.;
RT   "Differential kinetics of engraftment and induction of CD10 on human
RT   pre-B leukemia cell lines in immune deficient scid mice.";
RL   Leukemia 6:8-17(1992).
//
RX   PubMed=2595371; DOI=10.1126/science.2595371;
RA   Kamel-Reid S., Letarte M., Sirard C., Doedens M., Grunberger T.,
RA   Fulop G.M., Freedman M.H., Phillips R.A., Dick J.E.;
RT   "A model of human acute lymphoblastic leukemia in immune-deficient
RT   SCID mice.";
RL   Science 246:1597-1600(1989).
//